Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Medis Pharma Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (1371)
ARTG (121)
Cancellation or suspension (26)
Listed medicine compliance report (5)
Prescription medicine registration (2)

Date

2025 (2)
2024 (1185)
2023 (3)
2022 (29)
2021 (106)
2020 (31)
2019 (6)
2018 (5)
2017 (47)
2016 (5)
2015 (29)
2014 (29)
2013 (17)
2012 (9)
2011 (12)
2010 (3)
2009 (7)

Results for "[search-keyword]"

Search

Sponsor content

1525 result(s) found, displaying 1261 to 1270

IRPRESTAN 75 irbesartan 75 mg tablets blister pack Cancelled under Section 30(1)(c) of the Act

16 June 2021

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
Suspended from ARTG - GN-RANITIDINE ranitidine 300mg (as hydrochloride) tablet bottle Cancelled under Section 30(1)(c) of the Act

16 June 2021

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
Suspended from ARTG - RANITIDINE-GA ranitidine (as hydrochloride) 150mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

16 June 2021

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
Suspended from ARTG - RANITIDINE WINTHROP ranitidine (as hydrochloride) 300mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

16 June 2021

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
Suspended from ARTG - RANITIDINE WINTHROP ranitidine (as hydrochloride) 150mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

16 June 2021

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
Suspended from ARTG - GN-RANITIDINE ranitidine 150mg (as hydrochloride) tablet bottle Cancelled under Section 30(1)(c) of the Act

16 June 2021

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
Suspended from ARTG - RANITIDINE-GA ranitidine (as hydrochloride) 300mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

16 June 2021

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
Suspended from ARTG - RANITIDINE-GA ranitidine 300mg (as hydrochloride) tablet bottle Cancelled under Section 30(1)(c) of the Act

16 June 2021

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
Suspended from ARTG - RANITIDINE-WT ranitidine 300mg (as hydrochloride) tablet bottle Cancelled under Section 30(1)(c) of the Act

16 June 2021

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
Suspended from ARTG - RANITIDINE-WT ranitidine 150mg (as hydrochloride) tablet bottle Cancelled under Section 30(1)(c) of the Act

16 June 2021

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd

Pages

First page
Previous page
…
Page 123
Page 124
Page 125
Page 126
Current page 127
Page 128
Page 129
Page 130
Page 131
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.